James L Chen, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 20 years
- University of California, Davis School of Medicine, 2006
Offices
1 location
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (415) 900-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102032 · Current
Licensed to practise in California · since 2007 · expires 2027-11-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Pacific Heights Surgery Center of San Francisco, L.P. dba Pacific Heights Surgery CenterAmbulatory Surgery Center · San Francisco, CA4.31% owner since 2014 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2026-05-14
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$76,993
Medicare paid this office $76,993 for 220 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 119 | $21,156 | $105 |
| New patient visit (45+ min) | 82 | $11,244 | $137 |
| Short return visit (20+ min) | 109 | $9,643 | $65 |
| Aspiration and/or injection of fluid from large joint | 57 | $7,935 | $46 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $4,652 | None |
See all 10 services
| Return visit (30+ min) | 119 | $21,156 | $105 |
| New patient visit (45+ min) | 82 | $11,244 | $137 |
| Short return visit (20+ min) | 109 | $9,643 | $65 |
| Aspiration and/or injection of fluid from large joint | 57 | $7,935 | $46 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $4,652 | None |
| New patient visit (30+ min) | 21 | $1,537 | $73 |
| X-ray of knee, 1-2 views | 39 | $1,386 | $30 |
| X-ray of knee, 3 views | 17 | $672 | $37 |
| X-ray of shoulder, minimum of 2 views | 17 | $635 | $32 |
| Injection, dexamethasone sodium phosphate, 1 mg | 48 | $8 | None |
Procedures Medicare counted
| Knee replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 18 | More than 60% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 135 | 125 | 136 | 155 | 146 | 172 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
220 Original Medicare patients in 2024. Average age 73 · Women 57% · Also on Medicaid 44% · Health risk score 0.76. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 73% · Diabetes 27% · Coronary heart disease 14% · Chronic kidney disease 14% · Cancer 10% · Depression 10% · COPD 7% · Atrial fibrillation 5%.
The office billed $314,864, Medicare allowed $105,633 and paid $76,993; for 970 services of 45 kinds; $4,661 of it was for drugs given in the office and $72,332 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 220 | 970 | 73 | 0.76 | $314,864 | $76,993 |
| 2023 | 260 | 989 | 73 | 0.84 | $407,857 | $88,162 |
| 2022 | 240 | 970 | 72 | 0.83 | $321,150 | $78,937 |
| 2021 | 262 | 1,074 | 73 | 0.93 | $409,941 | $97,619 |
| 2020 | 206 | 889 | 72 | 0.87 | $292,619 | $59,813 |
| 2019 | 250 | 1,143 | 72 | 0.84 | $395,698 | $83,471 |
| 2018 | 246 | 931 | 71 | 1.03 | $287,079 | $62,306 |
| 2017 | 196 | 899 | 72 | 1.05 | $251,537 | $57,057 |
| 2016 | 191 | 800 | 73 | 0.95 | $205,267 | $50,123 |
| 2015 | 248 | 957 | 74 | 1.03 | $228,263 | $60,832 |
| 2014 | 287 | 1,462 | 74 | 0.90 | $335,075 | $98,508 |
| 2013 | 333 | 1,306 | 74 | 1.12 | $298,709 | $127,006 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 175 | $21,455 | $74 |
| New patient visit (30+ min) | 122 | $10,441 | $86 |
| Aspiration and/or injection of fluid from large joint | 66 | $6,994 | $48 |
| Return visit (30+ min) | 44 | $5,169 | $103 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $3,157 | None |
| New patient visit (45+ min) | 24 | $2,865 | $119 |
| Imaging guidance for procedure, 60 minutes or less | 29 | $1,412 | $40 |
| X-ray of knee, 1-2 views | 38 | $1,399 | $30 |
| X-ray of shoulder, minimum of 2 views | 15 | $555 | $31 |
| Injection, dexamethasone sodium phosphate, 1 mg | 56 | $9 | None |
2022: 9 services
| Short return visit (20+ min) | 158 | $20,414 | $75 |
| New patient visit (30+ min) | 112 | $9,271 | $83 |
| Aspiration and/or injection of fluid from large joint | 61 | $7,343 | $47 |
| Return visit (30+ min) | 39 | $5,368 | $112 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $4,492 | None |
| New patient visit (45+ min) | 34 | $4,327 | $127 |
| X-ray of knee, 1-2 views | 40 | $1,612 | $31 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $1,208 | $34 |
| Injection, dexamethasone sodium phosphate, 1 mg | 54 | $8 | None |
2021: 11 services
| Short return visit (20+ min) | 131 | $15,009 | $77 |
| Return visit (30+ min) | 80 | $11,405 | $113 |
| New patient visit (45+ min) | 64 | $8,648 | $135 |
| New patient visit (30+ min) | 91 | $7,164 | $79 |
| Aspiration and/or injection of fluid from large joint | 72 | $6,733 | $50 |
| X-ray of knee, 1-2 views | 44 | $2,570 | $34 |
| X-ray of both knees while standing | 35 | $1,483 | $41 |
| Short return visit | 22 | $1,220 | $45 |
| X-ray of shoulder, minimum of 2 views | 12 | $692 | $33 |
| Imaging guidance for procedure, 60 minutes or less | 11 | $265 | $20 |
| Injection, dexamethasone sodium phosphate, 1 mg | 70 | $12 | None |
2020: 11 services
| Short return visit (20+ min) | 118 | $11,853 | $61 |
| New patient visit (30+ min) | 107 | $7,957 | $74 |
| Aspiration and/or injection of fluid from large joint | 74 | $5,673 | $45 |
| Return visit (30+ min) | 22 | $2,102 | $96 |
| Short return visit | 34 | $1,429 | $35 |
| X-ray of knee, 1-2 views | 34 | $1,398 | $27 |
| X-ray of knee, 4 or more views | 16 | $646 | $40 |
| X-ray of shoulder, minimum of 2 views | 11 | $469 | $29 |
| X-ray of shoulder, 1 view | 23 | $405 | $17 |
| X-ray of knee, 3 views | 11 | $398 | $36 |
| Injection, dexamethasone sodium phosphate, 1 mg | 70 | $11 | None |
2019: 14 services
| Short return visit (20+ min) | 134 | $12,915 | $59 |
| New patient visit (30+ min) | 134 | $10,837 | $81 |
| Aspiration and/or injection of fluid from large joint | 81 | $6,635 | $49 |
| Short return visit | 64 | $3,375 | $40 |
| Return visit (30+ min) | 29 | $2,670 | $86 |
| X-ray of knee, 1-2 views | 39 | $2,223 | $30 |
| X-ray of knee, 3 views | 24 | $1,014 | $38 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 12 | $797 | $66 |
| X-ray of knee, 4 or more views | 21 | $796 | $35 |
| X-ray of ankle, minimum of 3 views | 11 | $709 | $28 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 12 | $579 | $48 |
| X-ray of shoulder, 1 view | 13 | $306 | $20 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 12 | $240 | $20 |
| Injection, dexamethasone sodium phosphate, 1 mg | 70 | $10 | None |
2018: 14 services
| New patient visit (30+ min) | 127 | $10,538 | $83 |
| Short return visit (20+ min) | 102 | $8,223 | $60 |
| Aspiration and/or injection of fluid from large joint | 78 | $5,213 | $47 |
| Return visit (30+ min) | 36 | $3,822 | $93 |
| New patient visit (45+ min) | 26 | $3,498 | $135 |
| Short return visit | 65 | $2,784 | $34 |
| X-ray of knee, 1-2 views | 27 | $1,324 | $28 |
| X-ray of knee, 4 or more views | 29 | $1,066 | $33 |
| X-ray of knee, 3 views | 13 | $474 | $34 |
| X-ray of wrist, minimum of 3 views | 11 | $366 | $30 |
| X-ray of shoulder, 1 view | 14 | $300 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $260 | $20 |
| Injection, methylprednisolone acetate, 40 mg | 20 | $121 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 67 | $8 | None |
2017: 14 services
| New patient visit (30+ min) | 90 | $8,166 | $91 |
| Aspiration and/or injection of fluid from large joint | 74 | $6,356 | $51 |
| Short return visit (20+ min) | 76 | $6,126 | $59 |
| Short return visit | 94 | $5,478 | $36 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $1,844 | None |
| Return visit (30+ min) | 14 | $1,415 | $94 |
| X-ray of knee, 1-2 views | 18 | $1,054 | $29 |
| New patient visit (15+ min) | 12 | $796 | $66 |
| X-ray of knee, 3 views | 17 | $556 | $31 |
| X-ray of knee, 4 or more views | 13 | $491 | $38 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $393 | $19 |
| Injection, methylprednisolone acetate, 40 mg | 68 | $370 | None |
| X-ray of shoulder, 1 view | 14 | $323 | $19 |
| Injection, dexamethasone sodium phosphate, 1 mg | 25 | $4 | None |
2016: 8 services
| Short return visit (20+ min) | 88 | $8,934 | $64 |
| New patient visit (30+ min) | 79 | $7,481 | $95 |
| Aspiration and/or injection of fluid from large joint | 56 | $4,052 | $51 |
| Short return visit | 79 | $3,848 | $34 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $2,019 | $78 |
| New patient visit (15+ min) | 17 | $877 | $52 |
| X-ray of knee, 3 views | 21 | $744 | $35 |
| Injection, methylprednisolone acetate, 40 mg | 59 | $330 | None |
2015: 11 services
| Short return visit (20+ min) | 121 | $12,163 | $63 |
| New patient visit (45+ min) | 77 | $10,735 | $139 |
| New patient visit (30+ min) | 85 | $8,049 | $95 |
| Return visit (30+ min) | 52 | $5,462 | $91 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 35 | $4,248 | $85 |
| Aspiration and/or injection of fluid from large joint | 45 | $3,002 | $51 |
| X-ray of knee, 3 views | 27 | $958 | $33 |
| Short return visit | 16 | $669 | $42 |
| X-ray of shoulder, 1 view | 12 | $272 | $23 |
| Injection, methylprednisolone acetate, 40 mg | 37 | $143 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 54 | $8 | None |
2014: 11 services
| Return visit (30+ min) | 172 | $29,882 | $91 |
| New patient visit (45+ min) | 170 | $24,079 | $142 |
| Ultrasonic guidance for needle placement | 76 | $9,802 | $73 |
| Aspiration and/or injection of fluid from large joint | 92 | $8,965 | $55 |
| New patient visit (30+ min) | 32 | $2,372 | $74 |
| X-ray of wrist, minimum of 3 views | 12 | $900 | $39 |
| Aspiration and/or injection of fluid from medium joint | 16 | $827 | $46 |
| X-ray of knee, 4 or more views | 15 | $624 | $42 |
| X-ray of shoulder, minimum of 2 views | 11 | $382 | $32 |
| Injection, methylprednisolone acetate, 40 mg | 32 | $81 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 80 | $15 | None |
2013: 12 services
| Ultrasonic guidance for needle placement | 110 | $33,836 | $217 |
| Return visit (30+ min) | 158 | $26,503 | $100 |
| New patient visit (45+ min) | 113 | $15,820 | $140 |
| New patient visit (30+ min) | 176 | $15,745 | $89 |
| Aspiration and/or injection of fluid from large joint | 115 | $8,957 | $56 |
| X-ray of wrist, minimum of 3 views | 17 | $1,618 | $35 |
| X-ray of knee, 4 or more views | 30 | $1,516 | $38 |
| Aspiration and/or injection of fluid from medium joint | 16 | $1,079 | $60 |
| X-ray of knee, 1-2 views | 11 | $530 | $31 |
| X-ray of shoulder, minimum of 2 views | 12 | $482 | $28 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $45 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 106 | $13 | None |
Medicaid work
$5,030 in 2024
Medicaid paid $5,030 for 137 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 55 | $3,619 |
| Short return visit (20+ min) | 82 | $1,411 |
| 2024 | 137 | 2 | 31 | $5,030 |
| 2023 | 439 | 2 | 34 | $12,929 |
| 2022 | 327 | 2 | 37 | $2,116 |
| 2021 | 401 | 5 | 30 | $5,022 |
| 2020 | 462 | 5 | 22 | $291 |
| 2019 | 133 | 2 | 20 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 335 | $8,142 |
| New patient visit (30+ min) | 104 | $4,787 |
2022
| Short return visit (20+ min) | 258 | $1,344 |
| New patient visit (30+ min) | 69 | $772 |
2021
| Short return visit (20+ min) | 181 | $1,671 |
| New patient visit (30+ min) | 86 | $1,328 |
| New patient visit (45+ min) | 57 | $1,101 |
| Return visit (30+ min) | 62 | $831 |
| Arthrocentesis and injection of knee joint | 15 | $92 |
2020
| Short return visit (20+ min) | 214 | $144 |
| Arthrocentesis and injection of knee joint | 54 | $92 |
| New patient visit (30+ min) | 113 | $56 |
| Injection, dexamethasone sodium phosphate, 1 mg | 42 | $0 |
| Lidocaine injection | 39 | $0 |
2019
| New patient visit (30+ min) | 50 | $0 |
| Short return visit (20+ min) | 83 | $0 |
Drugs they prescribed that Part D paid
$25,610
Pharmacies billed $25,610 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 18% of their Part D prescriptions (57 of 315) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
305 generic and fewer than 11 brand-name prescriptions · $25,610 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Meloxicam | 142 | $345 | $2 |
| Hydrocodone-Acetaminophen | 47 | $338 | $7 |
| Diclofenac | 12 | $177 | $15 |
| Ondansetron | 41 | $142 | $3 |
Year by year
| 2024 | 315 | 137 | 18% (57) | None | $25,610 |
| 2023 | 411 | 157 | 17% (71) | None | $17,825 |
| 2022 | 564 | 156 | 15% (87) | 11% | $22,979 |
| 2021 | 415 | 147 | 28% (115) | None | $6,146 |
| 2020 | 211 | 101 | 36% (75) | None | $3,666 |
| 2019 | 202 | 99 | 30% (60) | None | $12,436 |
| 2018 | 202 | 95 | 41% (82) | 9% | $23,552 |
| 2017 | 283 | 102 | 39% (111) | 16% | $40,400 |
| 2016 | 256 | 93 | 45% (116) | 13% | $45,368 |
| 2015 | 265 | 115 | 30% (80) | 19% | $64,986 |
| 2014 | 247 | 121 | 21% (51) | 33% | $32,963 |
| 2013 | 207 | 128 | 16% (32) | None | $12,484 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Meloxicam | 204 | $1,435 | $7 |
| Diclofenac | 27 | $615 | $23 |
| Hydrocodone-Acetaminophen | 62 | $545 | $9 |
| Ondansetron | 45 | $271 | $6 |
2022: 9 drugs
| Lantus Solostar | 21 | $3,270 | $156 |
| Autoshield Duo Pen Needle | 12 | $1,097 | $91 |
| Diclofenac | 36 | $856 | $24 |
| Hydrocodone-Acetaminophen | 68 | $700 | $10 |
| Meloxicam | 144 | $623 | $4 |
| Telmisartan | 12 | $536 | $45 |
| Ondansetron | 49 | $332 | $7 |
| Atorvastatin | 11 | $196 | $18 |
| Pantoprazole | 13 | $72 | $6 |
2021: 5 drugs
| Hydrocodone-Acetaminophen | 83 | $702 | $8 |
| Diclofenac | 34 | $693 | $20 |
| Meloxicam | 117 | $515 | $4 |
| Ondansetron | 58 | $285 | $5 |
| Ibuprofen | 22 | $181 | $8 |
2020: 4 drugs
| Hydrocodone-Acetaminophen | 64 | $567 | $9 |
| Diclofenac | 13 | $318 | $24 |
| Ondansetron | 38 | $209 | $6 |
| Meloxicam | 41 | $192 | $5 |
2019: 4 drugs
| Hydrocodone-Acetaminophen | 53 | $445 | $8 |
| Diclofenac | 13 | $387 | $30 |
| Naproxen | 29 | $378 | $13 |
| Ondansetron | 34 | $188 | $6 |
2018: 3 drugs
| Hydrocodone-Acetaminophen | 72 | $855 | $12 |
| Ondansetron | 32 | $232 | $7 |
| Naproxen | 21 | $193 | $9 |
2017: 5 drugs
| Forteo | 12 | $35,272 | $2,939 |
| Hydrocodone-Acetaminophen | 86 | $846 | $10 |
| Humulin R | 12 | $589 | $49 |
| Ondansetron | 41 | $226 | $6 |
| Ibuprofen | 26 | $164 | $6 |
2016: 6 drugs
| Forteo | 15 | $37,192 | $2,479 |
| Hydrocodone-Acetaminophen | 74 | $1,196 | $16 |
| Oxycodone | 19 | $309 | $16 |
| Ibuprofen | 38 | $287 | $8 |
| Ondansetron | 20 | $99 | $5 |
| Tramadol | 13 | $48 | $4 |
2015: 8 drugs
| Forteo | 21 | $46,842 | $2,231 |
| Celecoxib | 21 | $2,670 | $127 |
| Lidocaine | 11 | $2,651 | $241 |
| Voltaren | 19 | $916 | $48 |
| Hydrocodone-Acetaminophen | 57 | $820 | $14 |
| Ibuprofen | 49 | $400 | $8 |
| Bd Ultra-Fine Pen Needle | 16 | $217 | $14 |
| Ondansetron | 15 | $102 | $7 |
2014: 9 drugs
| Forteo | 11 | $17,595 | $1,600 |
| Celebrex | 19 | $4,360 | $229 |
| Lidocaine | 17 | $3,938 | $232 |
| Lidoderm | 12 | $3,228 | $269 |
| Voltaren | 37 | $1,663 | $45 |
| Hydrocodone-Acetaminophen | 34 | $407 | $12 |
| Ibuprofen | 53 | $330 | $6 |
| Methylprednisolone | 11 | $245 | $22 |
| Bd Ultra-Fine Pen Needle | 12 | $124 | $10 |
2013: 5 drugs
| Lidoderm | 26 | $7,200 | $277 |
| Voltaren | 32 | $1,320 | $41 |
| Ibuprofen | 71 | $410 | $6 |
| Methylprednisolone | 16 | $404 | $25 |
| Hydrocodone-Acetaminophen | 26 | $149 | $6 |
Money from drug and device companies
$666 in 2025
| 2025 | 3 | 3 | $500 | $666 |
| 2024 | 3 | 3 | $900 | $2,793 |
| 2023 | 3 | 43 | $7,857 | $11,544 |
| 2022 | 2 | 48 | $17,689 | $21,804 |
| 2021 | 4 | 57 | $26,467 | $31,118 |
| 2020 | 4 | 26 | $21,069 | $21,855 |
| 2019 | 3 | 62 | $57,049 | $61,812 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arthrex | None | $500 | 1 payment
|
| Medical Device Business Services | Actis | $128 | 1 payment
|
| Orthofix Medical | Physio-Stim | $38 | 1 payment
|
See all 3 published payments
| Medical Device Business Services | Meals · 2025-10-24 | Actis | $128 |
| Arthrex | Consulting · 2025-05-08 | None | $500 |
| Orthofix Medical | Meals · 2025-03-31 | Physio-Stim | $38 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,793
| Arthrex | None | $1,765 | 1 payment
|
| Davol | None | $900 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $129 | 1 payment
|
2023: $11,544
| Arthrex | None | $11,316 | 41 payments
|
| Ge Healthcare | Muse | $199 | 1 payment
|
| Evolution Surgical | None | $30 | 1 payment
|
2022: $21,804
| Arthrex | None | $21,775 | 47 payments
|
| Zimmer Biomet Holdings | None | $29 | 1 payment
|
2021: $31,118
| Arthrex | None | $30,807 | 49 payments
|
| Stryker | Mako | $166 | 5 payments
|
| Engage Uni | Engage Partial Knee System | $114 | 1 payment
|
| Omeros | Omidria | $31 | 2 payments
|
2020: $21,855
| Arthrex | None | $21,524 | 5 payments
|
| Omeros | Omidria | $297 | 19 payments
|
| Axogen | Avance Nerve Graft | $24 | 1 payment
|
| Dynasplint Systems | Dynasplint | $11 | 1 payment
|
2019: $61,812
| Arthrex | Arthroplasty Implants Knee & Hip Arthroplasty Uni Knee | $61,508 | 60 payments
|
| Joint Restoration Foundation | None | $188 | 1 payment
|
| Evolution Surgical | None | $117 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Avanos Medical · Malbec Tka 1 · 2019 | Their institution | $7,000 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1306040548
- Licence
- CA A102032California A102032: Current · expires 2027-11-30
- Trained
- University of California, Davis School of Medicine, 2006 · 20 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 450 Sutter St, Suite 400, San Francisco, CA, 94108
- NPI first listed
- 2007-06-12
- NPI last updated
- 2025-04-10
- NPI record certified
- 2025-04-10
This is when the NPI record was last certified, not a medical board exam.